The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial-Reference-Cited by-同舟云学术

The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial

Published:2019-05-31 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Weed Donald T.,Zilio Serena,Reis Isildinha M.,Sargi Zoukaa,Abouyared Marianne,Gomez-Fernandez Carmen R.,Civantos Francisco J.,Rodriguez Carla P.,Serafini Paolo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference67 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol.,2017

2. Cancer statistics, 2015;Siegel;CA Cancer J Clin.,2015

3. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma;Janot;J Clin Oncol.,2008

4. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?;Goodwin;Laryngoscope.,2000

5. Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts;Linehan;J Clinl Oncol.,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for HPV negative head and neck squamous cell carcinoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer;International Journal of Molecular Medicine;2024-07-01

3. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies;Immunology Letters;2024-06

4. Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy;American Society of Clinical Oncology Educational Book;2024-06

5. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16